(Q36598115)

15 August 2017

1 reference

title

Use of non-aspirin nonsteroidal antiinflammatory drugs and the risk of cardiovascular events (English)

1 reference

15 August 2017

1 reference

Judy W M Cheng

1

1 reference

15 August 2017

language of work or name

English

0 references

publication date

19 September 2006

1 reference

Annals of Pharmacotherapy

15 August 2017

published in

1 reference

15 August 2017

volume

40

1 reference

15 August 2017

issue

10

1 reference

15 August 2017

page(s)

1785-1796

1 reference

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

15 August 2017

cites work

1 reference

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

21 January 2018

1 reference

Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects

21 January 2018

1 reference

Effect of racemic ibuprofen dose on the magnitude and duration of platelet cyclo-oxygenase inhibition: relationship between inhibition of thromboxane production and the plasma unbound concentration of S(+)-ibuprofen.

21 January 2018

1 reference

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study

21 January 2018

1 reference

COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease

21 January 2018

1 reference

Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly

21 January 2018

1 reference

The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults

21 January 2018

1 reference

Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events

21 January 2018

1 reference

Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population

21 January 2018

1 reference

Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

21 January 2018

1 reference

Nonsteroidal anti-inflammatory drug use and acute myocardial infarction

21 January 2018

1 reference

Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis

21 January 2018

1 reference

Association between naproxen use and protection against acute myocardial infarction

21 January 2018

1 reference

Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction

21 January 2018

1 reference

The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin

21 January 2018

1 reference

Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction

21 January 2018

1 reference

Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study

21 January 2018

1 reference

Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction

21 January 2018

1 reference

Potential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction (MI)

21 January 2018

1 reference

Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells

21 January 2018

1 reference

Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1H048

1 reference

15 August 2017

1 reference